Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Bahaa Alhabil"'
Autor:
Audrey Besnard, C. Roig, Bahaa Alhabil, J.P. Saal, Kostantinos Zannis, Zoheir Mami, N. Khallil, Christophe Caussin, Aurélie Veugeois, Nicolas Amabile, Jean-Luc Monin, Mathieu Debauchez, François Raoux
Publikováno v:
Archives of Cardiovascular Diseases Supplements. 11:146
Background Although solid tumors and haematological malignancies represent a significant percentage of all pericardial effusion cases, the characteristics, optimal therapeutic management strategy (percutaneous pericardiocentesis (PPC) or surgical dra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ec7532df9db189c40ae4026eadee0de
https://doi.org/10.1016/j.acvdsp.2018.10.324
https://doi.org/10.1016/j.acvdsp.2018.10.324
Publikováno v:
Archives of Cardiovascular Diseases Supplements. 8(3)
Background The new balloon-expandable valve SAPIEN 3 provide a superiority over previous device, in a broader range of patients, with better accuracy in valve positioning and less paravalvular regurgitation. We aimed to evaluate periprocedural and sh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b7f2a981bd61160c1fa7c34d4abcc1b
Autor:
Luc Drieu, François Philippe, Bahaa Alhabil, Aurélie Veugeois, Alain Dibie, Christophe Caussin, Nicolas Amabile
Publikováno v:
Archives of Cardiovascular Diseases Supplements. 8:62-63
BackgroundParavalvular aortic regurgitation (PAR) after TAVR has been associated with increased mortality. The Sapien 3 device (Edwards Life-sciences) is different than the prior devices released by the same manufacturer in that it has a skirt design
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9198cc906f98395551da4c7409af936e
https://doi.org/10.1016/s1878-6480(16)30186-0
https://doi.org/10.1016/s1878-6480(16)30186-0
Publikováno v:
Archives of Cardiovascular Diseases Supplements. 9:60
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b19267764e3b7fdc61f59b614a15316
https://doi.org/10.1016/s1878-6480(17)30192-1
https://doi.org/10.1016/s1878-6480(17)30192-1
Autor:
Christophe Caussin, Aurélie Veugeois, Bahaa Alhabil, François Philippe, Nicolas Amabile, Alain Dibie
Publikováno v:
Journal of the American College of Cardiology. 66:B255-B256
The SAPIEN 3 (Edwards Lifescience) balloon-expandable valve incorporates a paravalvular sealing system, an active 3-dimensional coaxial positioning catheter, and is compatible with a 14-F expandable sheath. These characteristics provide a theoretical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a38befbde7d9099fec4e2b8afaa838a2
https://doi.org/10.1016/j.jacc.2015.08.645
https://doi.org/10.1016/j.jacc.2015.08.645
Publikováno v:
JACC: Cardiovascular Interventions. 9:S43
Few data is available comparing the latest generation Edwards SAPIEN 3 -S3 with Edwards SAPIEN XT- S XT in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI). To evaluate periprocedural and 30-day clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebac2dbfd5e4d517d181dba83e5369e6
https://doi.org/10.1016/j.jcin.2015.12.229
https://doi.org/10.1016/j.jcin.2015.12.229
Autor:
Bahaa Alhabil, Christophe Caussin, Zoheir Mami, Aurélie Veugeois, Nicolas Amabile, Luc Drieu, Alain Dibie, François Philippe
Publikováno v:
Archives of Cardiovascular Diseases Supplements. 8:60
BackgroundFew data is available concerning the latest generation Edwards SAPIEN 3- S3 in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI).AimsTo evaluate periprocedural and 30-day clinical outcomes of TAV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8064e659e5c16c5afa0bf0f35161a3ab
https://doi.org/10.1016/s1878-6480(16)30180-x
https://doi.org/10.1016/s1878-6480(16)30180-x
Autor:
Bahaa Alhabil
Publikováno v:
Journal of the American College of Cardiology. 66:B287
Only rare reports have been published about redo PMV and data regarding its long term safety and efficacy are scarce. So we decided to explore the immediate and long-term outcomes of repeat (redo) percutaneous mitral valvuloplasty (PMV) in a series o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c7e8df905ea1a62386080fa0d98da80
https://doi.org/10.1016/j.jacc.2015.08.725
https://doi.org/10.1016/j.jacc.2015.08.725